Literature DB >> 6159329

Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis.

M P Langford, M Yin-Murphy, Y M Ho, J C Barber, S Baron, G J Stanton.   

Abstract

We report the levels of coxsackievirus type A24 (CA24) and the levels and type of interferon produced early during naturally acquired picornavirus epidemic conjunctivitis. Virus levels ranging from 10(1.8) to 10(5.8) 50% tissue culture infective doses per ml were detected in 29 of 37 acute (collected 1 to 4 days after onset of conjunctivitis) tear samples. Interferon (10(1.5) to 10(3.3) U/ml) was detected in 12 of 29 tear samples collected on day 1, in 2 of 6 tear samples collected on day 2, and in 1 tear sample collected on day 3 after onset of conjunctivitis. The interferon activity in pooled tear samples was completely neutralized by antiserum against human fibroblast interferon, stable at pH 2.0, and active against different viruses. In addition, the interferon activity in tears, like human fibroblast and leukocyte interferons produced in vitro, protected human and rabbit, but not mouse, cells. This is the first report of production and identification of the antigenic type of interferon induced by an enterovirus during natural infection. The early appearance of fibroblast interferon suggests that it may be an important host defense at the local site of implantation against this and possibly other enterovirus infections.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159329      PMCID: PMC551229          DOI: 10.1128/iai.29.3.995-998.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Apollo 11 disease or acute hemorrhagic conjunctivitis: a pandemic of a new enterovirus infection of the eyes.

Authors:  R Kono
Journal:  Am J Epidemiol       Date:  1975-05       Impact factor: 4.897

2.  INTERFERON IN DERMAL CRUSTS OF HUMAN VACCINIA VIRUS VACCINATIONS POSSIBLE EXPLANATION OF RELATIVE BENIGNITY OF VARIOLATION SMALLPOX.

Authors:  E F WHEELOCK
Journal:  Proc Soc Exp Biol Med       Date:  1964-12

3.  CIRCULATING INTERFERON AFTER MEASLES VACCINATION.

Authors:  J K PETRALLI; T C MERIGAN; J R WILBUR
Journal:  N Engl J Med       Date:  1965-07-22       Impact factor: 91.245

4.  A coxsackievirus type A24 epidemic of acute conjunctivitis.

Authors:  M Yin-Murphy; K H Lim; Y M Ho
Journal:  Southeast Asian J Trop Med Public Health       Date:  1976-03       Impact factor: 0.267

5.  Efficient transfer of interferon-induced virus resistance between human cells.

Authors:  J E Blalock; G J Stanton
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

6.  Interferon in congenital rubella: response to live attenuated measles vaccine.

Authors:  J Desmyter; W E Rawls; J L Melnick; M D Yow; F F Barrett
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

7.  Interferon in human infections with St. Louis encephalitis virus.

Authors:  J P Luby; W E Stewart; S E Sulkin; J P Sanford
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

8.  Tumour cell lines induce interferon in human lymphocytes.

Authors:  G Trinchieri; D Santoli; B B Knowles
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

9.  Interferon in the cerebrospinal fluid of children with central nervous system disorders.

Authors:  R P Larke
Journal:  Can Med Assoc J       Date:  1967-01-07       Impact factor: 8.262

10.  Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen.

Authors:  M J Valle; A M Bobrove; S Strober; T C Merigan
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

View more
  5 in total

1.  Topical human fibroblast interferon for acute adenoviral conjunctivitis.

Authors:  K R Wilhelmus; E C Dunkel; J Herson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

2.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

3.  Activity of arildone with or without interferon against acute hemorrhagic conjunctivitis viruses in cell culture.

Authors:  M P Langford; D J Carr; M Yin-Murphy
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

4.  Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection.

Authors:  M P Langford; A L Villarreal; G J Stanton
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

5.  Acute hemorrhagic conjunctivitis: anti-coxsackievirus A24 variant secretory immunoglobulin A in acute and convalescent tear.

Authors:  Marlyn P Langford; Edwin A Anders; Maxwell A Burch
Journal:  Clin Ophthalmol       Date:  2015-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.